PT846689E - Compostos de benzimidazole - Google Patents

Compostos de benzimidazole

Info

Publication number
PT846689E
PT846689E PT97309761T PT97309761T PT846689E PT 846689 E PT846689 E PT 846689E PT 97309761 T PT97309761 T PT 97309761T PT 97309761 T PT97309761 T PT 97309761T PT 846689 E PT846689 E PT 846689E
Authority
PT
Portugal
Prior art keywords
halo
phenyl
alkyl
independently
alkylsulfinyl
Prior art date
Application number
PT97309761T
Other languages
English (en)
Inventor
Takashi Mano
Rodney W Stevens
Yoshiyuki Okumura
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT846689E publication Critical patent/PT846689E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT97309761T 1996-12-09 1997-12-03 Compostos de benzimidazole PT846689E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9601395 1996-12-09

Publications (1)

Publication Number Publication Date
PT846689E true PT846689E (pt) 2004-06-30

Family

ID=11004502

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97309761T PT846689E (pt) 1996-12-09 1997-12-03 Compostos de benzimidazole

Country Status (9)

Country Link
EP (1) EP0846689B1 (pt)
JP (1) JP3439643B2 (pt)
AT (1) ATE257825T1 (pt)
BR (1) BR9706241A (pt)
CA (1) CA2223551C (pt)
DE (1) DE69727199T2 (pt)
DK (1) DK0846689T3 (pt)
ES (1) ES2212054T3 (pt)
PT (1) PT846689E (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256513B2 (ja) * 1998-02-11 2002-02-12 ファイザー製薬株式会社 ベンゾイミダゾールシクロオキシゲナーゼ−2阻害剤
DE69942801D1 (de) 1998-05-26 2010-11-11 Chugai Pharmaceutical Co Ltd Heterozyklische indolderivate und mono- oder diazaindol-derivate
US6291499B1 (en) * 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US7695736B2 (en) 2001-04-03 2010-04-13 Pfizer Inc. Reconstitutable parenteral composition
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US7442709B2 (en) 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
EP1664021A1 (en) 2003-08-21 2006-06-07 OSI Pharmaceuticals, Inc. N-substituted benzimidazolyl c-kit inhibitors
RU2006108791A (ru) 2003-08-21 2006-07-27 Оси Фармасьютикалз, Инк. (Us) N-замещенные пиразолиламидилбензимидазолилы в качестве с-kit ингибиторов
JP2008521903A (ja) 2004-12-01 2008-06-26 オーエスアイ・ファーマスーティカルズ・インコーポレーテッド N置換されたベンズイミダゾリルC−kit阻害剤及びコンビナトリアルベンゾイミダゾールライブラリー
US7442716B2 (en) 2004-12-17 2008-10-28 Merck Frosst Canada Ltd. 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors
AU2005316091B2 (en) * 2004-12-17 2011-12-01 Merck Canada Inc. 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-D]imidazoles as mPGES-1 inhibitors
EP2019675A4 (en) * 2006-05-02 2011-03-02 Merck Frosst Canada Ltd METHODS FOR TREATING OR PREVENTING NEOPLASIA
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease
CN114656418B (zh) * 2022-04-10 2024-01-26 同济大学 一类(e)-苯并五元环-苯乙烯基硫鎓盐衍生物及其制备和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH542853A (de) * 1967-07-26 1973-10-15 Agripat Sa Verfahren zur Herstellung neuer Isothiocyano-benzazol-Derivate
DE1962353A1 (de) * 1969-12-12 1971-06-16 Bayer Ag Styrylaufheller
JPS5013795B2 (pt) * 1972-12-12 1975-05-22
JPS5975257A (ja) * 1982-10-23 1984-04-27 Ricoh Co Ltd 電子写真用感光体
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
JPH06194780A (ja) * 1992-12-24 1994-07-15 Konica Corp ハロゲン化銀写真乳剤

Also Published As

Publication number Publication date
JPH10168066A (ja) 1998-06-23
CA2223551A1 (en) 1998-06-09
EP0846689A1 (en) 1998-06-10
DE69727199T2 (de) 2004-11-18
MX9710034A (es) 1998-06-30
JP3439643B2 (ja) 2003-08-25
ES2212054T3 (es) 2004-07-16
EP0846689B1 (en) 2004-01-14
DE69727199D1 (de) 2004-02-19
DK0846689T3 (da) 2004-04-19
BR9706241A (pt) 1999-05-18
CA2223551C (en) 2004-02-10
ATE257825T1 (de) 2004-01-15

Similar Documents

Publication Publication Date Title
PT846689E (pt) Compostos de benzimidazole
DK0418845T3 (da) Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme
PH30916A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same.
MY149038A (en) Cinnamide compound
NZ507144A (en) Benzamide derivatives useful for the treatment of diseases mediated by cytokines
BR9900565A (pt) Inibidores de ciclooxigenase-2 de benzimidazol.
DK0985666T3 (da) Substituerede indolforbindelser som COX-2-inhibitorer
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
EP2471531A3 (en) Nitro-styrene derivatives having antimicrobial activity
DK1106614T3 (da) 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
MX9206930A (es) Nuevos compuestos
AU2001228862A1 (en) Remedies or preventives for liver diseases containing diaminotrifluoromethylpyridine derivatives
TW275629B (pt)
EP0653207A4 (en) AIDS VIRUS INFECTIVE COMPOSITION.
ES2102512T3 (es) Inhibidor de la hipertrofia de vasos sanguineos.
TR22776A (tr) Sinerjistik herbisidal terkipler